Multisystemic Inflammation Influences Prognosis in Fulminant Lymphocytic Myocarditis
BACKGROUND: Multisystem inflammatory syndrome (MIS) is a hyperinflammatory shock associated with cardiac dysfunction and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, there are no reports on using MIS criteria, such as multisystemic inflammation (MSI) in fulminant myocarditis, without SARS-CoV-2 infection. This study investigated the differences in clinical characteristics and course between patients with fulminant lymphocytic myocarditis (FLM) plus MSI and those without MSI.Methods and Results: This multicenter retrospective cohort study included 273 patients with FLM registered in the JROAD-DPC database between April 2014 and March 2017. We evaluated the presence of MSI using criteria modified from previously reported MIS criteria and compared the characteristics and risk of mortality or heart transplantation between FLM patients with MSI and without MSI. Of the 273 patients with FLM, 107 (39%) were diagnosed with MSI. The MSI group was younger (44 vs. 57 years; P<0.0001) and had more females (50% vs. 36%; P=0.0236), a higher incidence of pericardial effusion (58% vs. 40%; P=0.0073), and a lower 90-day mortality rate (19% vs. 33%; P=0.0185) than the non-MSI group. The risk of mortality at 90 days was lower in FLM patients aged <50 years with MSI aged <50 years than in those without MSI (P=0.0463).
CONCLUSIONS: These results suggest that MSI may influence the prognosis of FLM, especially in patients aged <50 years.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Circulation journal : official journal of the Japanese Circulation Society - 88(2024), 5 vom: 25. Apr., Seite 722-731 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kawano, Hiroaki [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical course |
|---|
| Anmerkungen: |
Date Completed 24.04.2024 Date Revised 24.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1253/circj.CJ-23-0914 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369228146 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369228146 | ||
| 003 | DE-627 | ||
| 005 | 20240425233030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240304s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1253/circj.CJ-23-0914 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM369228146 | ||
| 035 | |a (NLM)38432947 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kawano, Hiroaki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multisystemic Inflammation Influences Prognosis in Fulminant Lymphocytic Myocarditis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.04.2024 | ||
| 500 | |a Date Revised 24.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Multisystem inflammatory syndrome (MIS) is a hyperinflammatory shock associated with cardiac dysfunction and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, there are no reports on using MIS criteria, such as multisystemic inflammation (MSI) in fulminant myocarditis, without SARS-CoV-2 infection. This study investigated the differences in clinical characteristics and course between patients with fulminant lymphocytic myocarditis (FLM) plus MSI and those without MSI.Methods and Results: This multicenter retrospective cohort study included 273 patients with FLM registered in the JROAD-DPC database between April 2014 and March 2017. We evaluated the presence of MSI using criteria modified from previously reported MIS criteria and compared the characteristics and risk of mortality or heart transplantation between FLM patients with MSI and without MSI. Of the 273 patients with FLM, 107 (39%) were diagnosed with MSI. The MSI group was younger (44 vs. 57 years; P<0.0001) and had more females (50% vs. 36%; P=0.0236), a higher incidence of pericardial effusion (58% vs. 40%; P=0.0073), and a lower 90-day mortality rate (19% vs. 33%; P=0.0185) than the non-MSI group. The risk of mortality at 90 days was lower in FLM patients aged <50 years with MSI aged <50 years than in those without MSI (P=0.0463) | ||
| 520 | |a CONCLUSIONS: These results suggest that MSI may influence the prognosis of FLM, especially in patients aged <50 years | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Clinical course | |
| 650 | 4 | |a Infection | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a Myocarditis | |
| 700 | 1 | |a Ikeda, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kanaoka, Koshiro |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Shuntaro |e verfasserin |4 aut | |
| 700 | 1 | |a Eto, Ryo |e verfasserin |4 aut | |
| 700 | 1 | |a Ueno, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Onoue, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Saito, Yoshihiko |e verfasserin |4 aut | |
| 700 | 1 | |a Maemura, Koji |e verfasserin |4 aut | |
| 700 | 0 | |a Japanese Registry of Fulminant Myocarditis Investigators |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation journal : official journal of the Japanese Circulation Society |d 2002 |g 88(2024), 5 vom: 25. Apr., Seite 722-731 |w (DE-627)NLM118044850 |x 1347-4820 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2024 |g number:5 |g day:25 |g month:04 |g pages:722-731 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1253/circj.CJ-23-0914 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2024 |e 5 |b 25 |c 04 |h 722-731 | ||